Hydroxychloroquine, Rheumatic Diseases And Covid

Novartis intends to work directly with other manufacturers to range up development of hydroxychloroquine as essential to support global resource, and promotes industry, governments and international institutions to ensure enough global supply of medications to take care of COVID-19 patients. Patients whose documents were analyzed received 400 mg of hydroxychloroquine twice on the first day,… Continue reading Hydroxychloroquine, Rheumatic Diseases And Covid